These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17428517)

  • 1. Entry inhibitor-based microbicides are active in vitro against HIV-1 isolates from multiple genetic subtypes.
    Ketas TJ; Schader SM; Zurita J; Teo E; Polonis V; Lu M; Klasse PJ; Moore JP
    Virology; 2007 Aug; 364(2):431-40. PubMed ID: 17428517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion.
    Veazey RS; Klasse PJ; Schader SM; Hu Q; Ketas TJ; Lu M; Marx PA; Dufour J; Colonno RJ; Shattock RJ; Springer MS; Moore JP
    Nature; 2005 Nov; 438(7064):99-102. PubMed ID: 16258536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
    Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
    AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a CCR5 inhibitor on viral loads in macaques dual-infected with R5 and X4 primate immunodeficiency viruses.
    Wolinsky SM; Veazey RS; Kunstman KJ; Klasse PJ; Dufour J; Marozsan AJ; Springer MS; Moore JP
    Virology; 2004 Oct; 328(1):19-29. PubMed ID: 15380354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor.
    Hatse S; Princen K; De Clercq E; Rosenkilde MM; Schwartz TW; Hernandez-Abad PE; Skerlj RT; Bridger GJ; Schols D
    Biochem Pharmacol; 2005 Sep; 70(5):752-61. PubMed ID: 16011832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tropism-independent protection of macaques against vaginal transmission of three SHIVs by the HIV-1 fusion inhibitor T-1249.
    Veazey RS; Ketas TA; Klasse PJ; Davison DK; Singletary M; Green LC; Greenberg ML; Moore JP
    Proc Natl Acad Sci U S A; 2008 Jul; 105(30):10531-6. PubMed ID: 18647836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbicides for multidrug-resistant and multitropic HIV-1.
    D'Cruz OJ; Uckun FM
    Curr Opin Investig Drugs; 2008 Feb; 9(2):152-69. PubMed ID: 18246518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of HIV prevention: prospects for an effective anti-HIV microbicide.
    Nuttall J; Romano J; Douville K; Galbreath C; Nel A; Heyward W; Mitchnick M; Walker S; Rosenberg Z
    Infect Dis Clin North Am; 2007 Mar; 21(1):219-39, x. PubMed ID: 17502237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of HIV-1 entry inhibitors with broad activity against R5 and X4 viral strains.
    Sironi F; Malnati M; Mongelli N; Cozzi P; Guzzo C; Ghezzi S; Martínez-Romero C; García-Sastre A; Lusso P; Jabes D; Biswas P
    J Transl Med; 2015 Apr; 13():107. PubMed ID: 25888743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5.
    Lederman MM; Veazey RS; Offord R; Mosier DE; Dufour J; Mefford M; Piatak M; Lifson JD; Salkowitz JR; Rodriguez B; Blauvelt A; Hartley O
    Science; 2004 Oct; 306(5695):485-7. PubMed ID: 15486300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Punica granatum (pomegranate) juice provides an HIV-1 entry inhibitor and candidate topical microbicide.
    Neurath AR; Strick N; Li YY; Debnath AK
    Ann N Y Acad Sci; 2005 Nov; 1056():311-27. PubMed ID: 16387698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of multiclade R5 and X4 human immunodeficiency virus type-1 infections by a coreceptor-based anti-HIV strategy.
    Nakayama D; Misumi S; Mukai R; Tachibana K; Umeda M; Shibata H; Takamune N; Shoji S
    J Biochem; 2005 Nov; 138(5):571-82. PubMed ID: 16272569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfated K5 Escherichia coli polysaccharide derivatives inhibit human immunodeficiency type-1 (HIV-1) infection: candidate microbicides to prevent sexual HIV transmission.
    Pacciarini F; Ghezzi S; Pinna D; Cima S; Zoppetti G; Oreste P; Poli G; Vicenzi E
    New Microbiol; 2004 Apr; 27(2 Suppl 1):5-9. PubMed ID: 15646059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relative activity of "function sparing" HIV-1 entry inhibitors on viral entry and CCR5 internalization: is allosteric functional selectivity a valuable therapeutic property?
    Muniz-Medina VM; Jones S; Maglich JM; Galardi C; Hollingsworth RE; Kazmierski WM; Ferris RG; Edelstein MP; Chiswell KE; Kenakin TP
    Mol Pharmacol; 2009 Mar; 75(3):490-501. PubMed ID: 19064629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of primary R5 HTV-1 to inhibition by RANTES correlates with sensitivity to small-molecule R5 inhibitors.
    Koning FA; Koevoets C; van der Vorst TJ; Schuitemaker H
    Antivir Ther; 2005; 10(2):231-7. PubMed ID: 15865217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ligand-based and receptor-based virtual screening of HIV entry inhibitors for the CXCR4 and CCR5 receptors using 3D ligand shape matching and ligand-receptor docking.
    Pérez-Nueno VI; Ritchie DW; Rabal O; Pascual R; Borrell JI; Teixidó J
    J Chem Inf Model; 2008 Mar; 48(3):509-33. PubMed ID: 18298095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of macaques from vaginal SHIV challenge by an orally delivered CCR5 inhibitor.
    Veazey RS; Springer MS; Marx PA; Dufour J; Klasse PJ; Moore JP
    Nat Med; 2005 Dec; 11(12):1293-4. PubMed ID: 16273102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective sequestration of X4 isolates by human genital epithelial cells: Implication for virus tropism selection process during sexual transmission of HIV.
    Berlier W; Bourlet T; Lawrence P; Hamzeh H; Lambert C; Genin C; Verrier B; Dieu-Nosjean MC; Pozzetto B; Delézay O
    J Med Virol; 2005 Dec; 77(4):465-74. PubMed ID: 16254974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotypic coreceptor analysis.
    Sierra S; Kaiser R; Thielen A; Lengauer T
    Eur J Med Res; 2007 Oct; 12(9):453-62. PubMed ID: 17933727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small-molecule HIV-1 gp120 inhibitors to prevent HIV-1 entry: an emerging opportunity for drug development.
    Kadow J; Wang HG; Lin PF
    Curr Opin Investig Drugs; 2006 Aug; 7(8):721-6. PubMed ID: 16955683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.